PDF DOWNLOAD (Last Updated: Aug 18, 2023)
Track A @International Conference Hall, 3F
09:00-11:00
Session 2A1: Mucin & Microbiome (SFG session)
Chairs: Stacy Malaker, Michael Tiemeyer
Chairs: Stacy Malaker, Michael Tiemeyer
09:00
Keynote 1: Katharina Ribbeck, Massachusetts Institute of Technology, USA
Mucin glycans in the regulation of microbial virulence (D024)
Mucin glycans in the regulation of microbial virulence (D024)
09:30
Keynote 2: Mario Feldman, Washington Univ., USA
Human gut bacteria tailor extracellular vesicle cargo for the breakdown of diet- and host-derived glycans (D025)
Human gut bacteria tailor extracellular vesicle cargo for the breakdown of diet- and host-derived glycans (D025)
10:00
Qiaochu Liang, Univ. of British Columbia, Canada
The role of mucin O-glycans in the interactions between enteric pathogens and the intestinal mucus (A046)
The role of mucin O-glycans in the interactions between enteric pathogens and the intestinal mucus (A046)
10:20
Toshihiko Katoh, Kyoto Univ., Japan
Bifidobacterium bifidum degrades sulfated mucin O-Glycans via a sulfatase-independent pathway (A050)
Bifidobacterium bifidum degrades sulfated mucin O-Glycans via a sulfatase-independent pathway (A050)
10:40
Ching-Ching Yu, National Tsing Hua Univ., Taiwan
Analyzing the substrate specificity of fucosidases from Bifidobacterium longum by supercritical fluid chromatography (C075)
Analyzing the substrate specificity of fucosidases from Bifidobacterium longum by supercritical fluid chromatography (C075)
11:00-11:20
Coffee Break
@Lobby, 4F
11:20
Plenary 3: Gunnar C Hansson, Univ. of Gothenburg, Sweden
The gel-forming mucins protecting our intestinal and respiratory tracts are densely glycosylated polymeric proteins (D006)
Chaired by: Henrik Clausen
The gel-forming mucins protecting our intestinal and respiratory tracts are densely glycosylated polymeric proteins (D006)
Chaired by: Henrik Clausen
12:00-13:20
Lunch
@Communal area, 3F
Luncheon Seminar 2: E. SUN FHC & Rock Biomedical, Inc.
@Recreation Hall, 4F
Chaired by: Jeng-Shin Lee
Alex Che Ma, Szu-Wen Wang, Chung-Yi Wu
Development of low sugar universal vaccine
Alex Che Ma, Szu-Wen Wang, Chung-Yi Wu
Development of low sugar universal vaccine
13:20
Plenary 4: Nathalie Juge, Quadram Institute, UK
Sialic acid metabolism in the gut microbiota (D007)
Chaired by: Anne Dell
Sialic acid metabolism in the gut microbiota (D007)
Chaired by: Anne Dell
14:00-16:00
Session 2A2: Structural Aspects of GBP in Cancer & Host-Microbe Interactions
Chairs: Yehiel Zick, Chun-Hung Lin
Chairs: Yehiel Zick, Chun-Hung Lin
14:00
Keynote 1: Kurt Drickamer, Imperial College London, UK
Mammalian lectin arrays for characterizing host-pathogen interactions (D026)
Mammalian lectin arrays for characterizing host-pathogen interactions (D026)
14:30
Keynote 2: Ute Krengel, Univ. of Oslo, Norway
Protein-carbohydrate interactions in infection and cancer biology (D027)
Protein-carbohydrate interactions in infection and cancer biology (D027)
15:00
Shang-Chuen Wu, Harvard Medical School, USA
Blood group A enhances SARS-CoV-2 infection (A071)
Blood group A enhances SARS-CoV-2 infection (A071)
15:15
Yoshiki Yamaguchi, Tohoku Medical and Pharmaceutical Univ., Japan
Glycan dynamics and glycan-protein interactions analyzed by experimental NMR methods, AlphaFold-assisted molecular dynamics and docking simulations (C074)
Glycan dynamics and glycan-protein interactions analyzed by experimental NMR methods, AlphaFold-assisted molecular dynamics and docking simulations (C074)
15:30
Sheng-Kai Wang, National Tsing Hua Univ., Taiwan
Manipulating carbohydrate interactions by polyproline-based nanoscaffolds (C073)
Manipulating carbohydrate interactions by polyproline-based nanoscaffolds (C073)
15:45
Travel Award: Cristina Di Carluccio, Univ. of Naples Federico II, Italy
Molecular details of α2–3-sialylated O-GalNAc glycan recognition by Siglec-like SLBR-N (SLBRUB10712) of Streptococcus gordonii (A038)
Molecular details of α2–3-sialylated O-GalNAc glycan recognition by Siglec-like SLBR-N (SLBRUB10712) of Streptococcus gordonii (A038)
Track B @2nd Conference Room, 3F
09:00-11:00
Session 2B1: Glycoconjugate Diversity from Non-mammal
Chairs: Shi Yan, Yves Hsieh
Chairs: Shi Yan, Yves Hsieh
09:00
Keynote 1: Katharina Paschinger, Univ. of Natural Resources and Life Sciences (BOKU), Austria
Glycans in host-parasite interactions (D028)
Glycans in host-parasite interactions (D028)
09:30
Keynote 2: Yann Guerardel, Lille Univ., France
Regulation of the biosynthesis of glycopeptidolipids in Mycobacterium abscessus (D029)
Regulation of the biosynthesis of glycopeptidolipids in Mycobacterium abscessus (D029)
10:00
Shinya Fushinobu, Univ. of Tokyo, Japan
Structural basis of endo/exo-α- and exo-β-D-arabinofuranosidases for the degradation of mycobacterial lipoarabinomanna (B054)
Structural basis of endo/exo-α- and exo-β-D-arabinofuranosidases for the degradation of mycobacterial lipoarabinomanna (B054)
10:20
Josef Voglmeir, Nanjing Agricultural Univ., China
Novel insights in the sialic acid biosynthesis in vertebrates and invertebrates (A148)
Novel insights in the sialic acid biosynthesis in vertebrates and invertebrates (A148)
10:40
Noriko Suzuki, Nagoya City Univ., Japan
Gain and loss of α4-galactosyltransferase-like genes in the course of vertebrate evolution (A146)
Gain and loss of α4-galactosyltransferase-like genes in the course of vertebrate evolution (A146)
14:00-16:00
Session 2B2: Glyco Analytics & Glycomics
Chairs: Daniel Kolarich, Jaroslav Katrlik
Chairs: Daniel Kolarich, Jaroslav Katrlik
14:00
Keynote 1: Manfred Wuhrer, Leiden Univ., Netherlands
Fingerprinting disease by mass spectrometry (D030)
Fingerprinting disease by mass spectrometry (D030)
14:30
Keynote 2: Morten Thaysen-Andersen, Macquarie Univ., Australia
Glycomics-guided glycoproteomics uncovers new players in the innate immune system (D031)
Glycomics-guided glycoproteomics uncovers new players in the innate immune system (D031)
15:00
Yanlong Ji, Max Planck Institute, Germany
Integrated proteomic and glycoproteomic characterization of diffuse large B cell lymphoma cell lines (C026)
Integrated proteomic and glycoproteomic characterization of diffuse large B cell lymphoma cell lines (C026)
15:15
Travel Award: Abarna Vidya Mohana Murugan, Griffith Univ., Australia
Phyloglycomics: Understanding species-specific evolution of the serum glycome – a step towards filling the knowledge gap in host-pathogen co-evolution (C042)
Phyloglycomics: Understanding species-specific evolution of the serum glycome – a step towards filling the knowledge gap in host-pathogen co-evolution (C042)
15:30
Lucia Pažitná,Slovak Academy of Sciences, Slorakia
Glycoprofiling of selected glycoproteins and blood components in gestational diabetes mellitus by lectin-based glycoprotein microarray method (C053)
Glycoprofiling of selected glycoproteins and blood components in gestational diabetes mellitus by lectin-based glycoprotein microarray method (C053)
15:45
Atsushi Kuno, National Institute of Advanced Industrial Science and Technology, Japan
Lectin dotcoding: A new output method miproving the effectiveness of automatic glycan profiling with 15-Lectin tip (C064)
Lectin dotcoding: A new output method miproving the effectiveness of automatic glycan profiling with 15-Lectin tip (C064)
Track C @1st Conference Room, 3F
09:00-11:00
Session 2C1: ACGG I
Chairs: Chuan-Fa Chang, Siva Kumar Nadimpalli
Chairs: Chuan-Fa Chang, Siva Kumar Nadimpalli
09:00
Keynote 1: Siva Kumar Nadimpalli, Univ. of Hyderabad, India
Glycosyl hydrolases from the seeds of Cucurbitaceae (D032)
Glycosyl hydrolases from the seeds of Cucurbitaceae (D032)
09:30
Keynote 2: Xuechen Li, Univ. of Hong Kong, Hong Kong
Chemical glycobiology studies on bacterial pseudaminic acid (D033)
Chemical glycobiology studies on bacterial pseudaminic acid (D033)
10:00
Keynote 3: Won Ho Yang, Yonsei Univ., Korea
A functional study of O-GlcNAcylation on RNA binding protein RBM14 (D034)
A functional study of O-GlcNAcylation on RNA binding protein RBM14 (D034)
10:30
Hirokazu Yagi, Nagoya City Univ., Japan
PCYT2-mediated glycerol phosphate modification of α-Dystroglycan disrupts matriglycan elongation and thereby enhances colorectal cancer metastasis (A087)
PCYT2-mediated glycerol phosphate modification of α-Dystroglycan disrupts matriglycan elongation and thereby enhances colorectal cancer metastasis (A087)
10:45
Yung-Kuo Lee, Kaohsiung Armed Forces General Hospital, Taiwan
Long-term DEHP/MEHP exposure promotes colorectal cancer stemness associated with glycosylation (A104)
Long-term DEHP/MEHP exposure promotes colorectal cancer stemness associated with glycosylation (A104)
14:00-16:00
Session 2C2: ACGG II
Chairs: Atit Silsirivanit, Yasuhiko Kizuka
Chairs: Atit Silsirivanit, Yasuhiko Kizuka
14:00
Keynote 1: Yasuhiko Kizuka, Gifu Univ., Japan
Regulation and protein selectivity of N-glycan branching enzymes (D035)
Regulation and protein selectivity of N-glycan branching enzymes (D035)
14:30
Keynote 2: Atit Silsirivanit, Khon Kaen Univ., Thailand
Glycan: A target for diagnosis and treatment of brain tumors (D036)
Glycan: A target for diagnosis and treatment of brain tumors (D036)
15:00
Kei-ichiro Inamori, Tohoku Medical and Pharmaceutical Univ., Japan
Altered expression of glycosphingolipids and its possible significance in ulcerative colitis (A114)
Altered expression of glycosphingolipids and its possible significance in ulcerative colitis (A114)
15:20
Kazuchika Nishitsuji, Wakayama Medical Univ., Japan
Glycan-mediated prion-like behavior of mutant p53 aggregates and their possible role in cancer pathogenesis (A089)
Glycan-mediated prion-like behavior of mutant p53 aggregates and their possible role in cancer pathogenesis (A089)
15:40
Pei-Shan Sung, Academia Sinica, Taiwan
Inhibition of SARS-CoV-2-mediated thromboinflammation by CLEC2.Fc (A075)
Inhibition of SARS-CoV-2-mediated thromboinflammation by CLEC2.Fc (A075)
@3rd & 4th Floor Hallway
16:00-18:00
Poster Session I (with Coffee served)
